Clinic Roundup
Depomed Inc., of Menlo Park, Calif., presented additional data from its Phase III trial, BREEZE 3, suggesting Serada, its nonhormonal extended-release formulation of gabapentin, may help manage menopausal hot flashes.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.